Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Kent

Showing results (181-190 of 390) with videos related to

Pageof 39
Sort By:
Advanced Healthcare Materials|February 14, 2023
Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune ResponsesMai N Vu, Emily H Pilkington, Wen Shi Lee, et al.
Nature Communications|March 25, 2023
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysisDeborah Cromer, Megan Steain, Arnold Reynaldi, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 11, 2013
Mechanically tunable, self-adjuvanting nanoengineered polypeptide particlesJiwei Cui, Robert De Rose, James P Best, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 8, 2020
Template-Mediated Assembly of DNA into Microcapsules for Immunological ModulationYijiao Qu, Yi Ju, Christina Cortez-Jugo, et al.
Journal of Neurovirology|August 9, 2003
Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virusKatherine A Thompson, Stephen J Kent, Michelle E Gahan, et al.
Nature Reviews. Immunology|November 3, 2020
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal modelsDavid S Khoury, Adam K Wheatley, Mitchell D Ramuta, et al.
Nature Communications|September 27, 2024
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updatesDeborah Cromer, Arnold Reynaldi, Ainslie Mitchell, et al.
Journal of Virology|January 26, 2007
Vaccine-induced T cells control reversion of AIDS virus immune escape mutantsCaroline S Fernandez, Miranda Z Smith, C Jane Batten, et al.
Vaccine|August 29, 2009
Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimensRob J Center, Adam K Wheatley, Shahan M Campbell, et al.
AIDS (London, England)|February 1, 2013
Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllersMartyn A French, Rob J Center, Kim M Wilson, et al.
Pageof 39

Showing results (181-190 of 390) with videos related to

Sort By:
Pageof 39
Advanced Healthcare Materials|February 14, 2023
Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune ResponsesMai N Vu, Emily H Pilkington, Wen Shi Lee, et al.
Nature Communications|March 25, 2023
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysisDeborah Cromer, Megan Steain, Arnold Reynaldi, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 11, 2013
Mechanically tunable, self-adjuvanting nanoengineered polypeptide particlesJiwei Cui, Robert De Rose, James P Best, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 8, 2020
Template-Mediated Assembly of DNA into Microcapsules for Immunological ModulationYijiao Qu, Yi Ju, Christina Cortez-Jugo, et al.
Journal of Neurovirology|August 9, 2003
Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virusKatherine A Thompson, Stephen J Kent, Michelle E Gahan, et al.
Nature Reviews. Immunology|November 3, 2020
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal modelsDavid S Khoury, Adam K Wheatley, Mitchell D Ramuta, et al.
Nature Communications|September 27, 2024
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updatesDeborah Cromer, Arnold Reynaldi, Ainslie Mitchell, et al.
Journal of Virology|January 26, 2007
Vaccine-induced T cells control reversion of AIDS virus immune escape mutantsCaroline S Fernandez, Miranda Z Smith, C Jane Batten, et al.
Vaccine|August 29, 2009
Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimensRob J Center, Adam K Wheatley, Shahan M Campbell, et al.
AIDS (London, England)|February 1, 2013
Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllersMartyn A French, Rob J Center, Kim M Wilson, et al.
Pageof 39